BrightAccountsProduction v1.0.0 v1.0.0 2024-04-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts Management consultancy activities other than financial management 28 August 2025 2 2 09913937 2025-03-31 09913937 2024-03-31 09913937 2023-03-31 09913937 2024-04-01 2025-03-31 09913937 2023-04-01 2024-03-31 09913937 uk-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09913937 uk-curr:PoundSterling 2024-04-01 2025-03-31 09913937 uk-bus:FullAccounts 2024-04-01 2025-03-31 09913937 uk-bus:Director1 2024-04-01 2025-03-31 09913937 uk-bus:Director2 2024-04-01 2025-03-31 09913937 uk-bus:RegisteredOffice 2024-04-01 2025-03-31 09913937 uk-bus:Agent1 2024-04-01 2025-03-31 09913937 uk-core:ShareCapital 2025-03-31 09913937 uk-core:ShareCapital 2024-03-31 09913937 uk-core:RetainedEarningsAccumulatedLosses 2025-03-31 09913937 uk-core:RetainedEarningsAccumulatedLosses 2024-03-31 09913937 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-03-31 09913937 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-03-31 09913937 uk-bus:FRS102 2024-04-01 2025-03-31 09913937 uk-core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 09913937 uk-core:WithinOneYear 2025-03-31 09913937 uk-core:WithinOneYear 2024-03-31 09913937 uk-core:AfterOneYear 2025-03-31 09913937 uk-core:AfterOneYear 2024-03-31 09913937 2024-04-01 2025-03-31 09913937 uk-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
Zanshin Labs Ltd
 
Directors' Report and Unaudited Financial Statements
 
for the financial year ended 31 March 2025
Zanshin Labs Ltd
DIRECTORS AND OTHER INFORMATION

 
Directors Ioannis Pagonis
Sotirios Sotiropoulos
 
 
Company Registration Number 09913937
 
 
Registered Office and Business Address 284a Chase Road
London
N14 6HF
United Kingdom
 
 
Accountants Pounnas Ltd
284a Chase Road
London
N14 6HF
United Kingdom



Zanshin Labs Ltd
DIRECTORS' REPORT
for the financial year ended 31 March 2025

 
The directors present their report and the unaudited financial statements for the financial year ended 31 March 2025.
 
Principal Activity
Management consultancy activities other than financial management
     
Directors
The directors who served during the financial year are as follows:
     
Ioannis Pagonis
Sotirios Sotiropoulos
   
     
Special provisions relating to small companies
The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
     
     
On behalf of the board
     
     
___________________________
Ioannis Pagonis
Director
     
28 August 2025



Zanshin Labs Ltd
INCOME STATEMENT
for the financial year ended 31 March 2025
2025 2024
Notes £ £

Turnover 188,479 34,615
 
Other external expenses (31,863) (16,354)
Staff costs (20,400) (20,400)
Depreciation on non-current assets (2,854) (972)
Other operating expenses (20,664) (13,826)
───────── ─────────
 
Profit/(loss) before taxation 112,698 (16,937)
 
Tax on profit/(loss) (24,103) 3,403
───────── ─────────
Profit/(loss) for the financial year 88,595 (13,534)
───────── ─────────
Total comprehensive income 88,595 (13,534)
    ═════════   ═════════



Zanshin Labs Ltd
Company Registration Number: 09913937
STATEMENT OF FINANCIAL POSITION
as at 31 March 2025

2025 2024
Notes £ £
 
Non-Current Assets
Property, plant and equipment 4 8,563 972
───────── ─────────
 
Current Assets
Debtors 5 24,074 4,063
Cash and cash equivalents 36,014 562
───────── ─────────
60,088 4,625
───────── ─────────
Creditors: amounts falling due within one year 6 (20,550) (6,091)
───────── ─────────
Net Current Assets/(Liabilities) 39,538 (1,466)
───────── ─────────
Total Assets less Current Liabilities 48,101 (494)
 
Creditors:
amounts falling due after more than one year 7 (200) (200)
───────── ─────────
Net Assets/(Liabilities) 47,901 (694)
═════════ ═════════
 
Capital and Reserves
Called up share capital 2 2
Retained earnings 47,899 (696)
───────── ─────────
Equity attributable to owners of the company 47,901 (694)
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The directors confirm that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The directors acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Board and authorised for issue on 28 August 2025 and signed on its behalf by
           
           
________________________________          
Ioannis Pagonis          
Director          
           



Zanshin Labs Ltd
NOTES TO THE FINANCIAL STATEMENTS
for the financial year ended 31 March 2025

   
1. General Information
 
Zanshin Labs Ltd is a company limited by shares incorporated and registered in the United Kingdom. The registered number of the company is 09913937. The registered office of the company is 284a Chase Road, London, N14 6HF, United Kingdom which is also the principal place of business of the company. The nature of the company's operations and its principal activities are set out in the Directors' Report. The financial statements have been presented in Pound (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the financial year ended 31 March 2025 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Turnover
Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.
 
Property, plant and equipment and depreciation
Property, plant and equipment are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of property, plant and equipment, less their estimated residual value, over their expected useful lives as follows:
 
  Fixtures, fittings and equipment - 25% Straight line
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Borrowing costs
Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Taxation and deferred taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Statement of Financial Position date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Statement of Financial Position date.
 
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Statement of Financial Position date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Income Statement.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
       
3. Employees
 
The average monthly number of employees, including directors, during the financial year was 2, (2024 - 2).
 
  2025 2024
  Number Number
 
Director 2 2
  ═════════ ═════════
       
4. Property, plant and equipment
  Fixtures, Total
  fittings and  
  equipment  
  £ £
Cost
At 1 April 2024 9,255 9,255
Additions 10,445 10,445
  ───────── ─────────
At 31 March 2025 19,700 19,700
  ───────── ─────────
Depreciation
At 1 April 2024 8,283 8,283
Charge for the financial year 2,854 2,854
  ───────── ─────────
At 31 March 2025 11,137 11,137
  ───────── ─────────
Net book value
At 31 March 2025 8,563 8,563
  ═════════ ═════════
At 31 March 2024 972 972
  ═════════ ═════════
       
5. Debtors 2025 2024
  £ £
 
Taxation  (Note 8) 24,074 4,063
  ═════════ ═════════
       
6. Creditors 2025 2024
Amounts falling due within one year £ £
 
Taxation  (Note 8) 17,876 1,263
Directors' current accounts 2,674 4,828
  ───────── ─────────
  20,550 6,091
  ═════════ ═════════
       
7. Creditors 2025 2024
Amounts falling due after more than one year £ £
 
Directors' loan accounts 200 200
  ═════════ ═════════
 
       
8. Taxation 2025 2024
  £ £
 
Debtors:
VAT 23,794 4,063
PAYE / NI 280 -
  ───────── ─────────
  24,074 4,063
  ═════════ ═════════
Creditors:
Corporation tax 17,876 1,263
  ═════════ ═════════